CANNABASE Trademark

Trademark Overview

On Friday, February 3, 2017, a trademark application was filed for CANNABASE with the United States Patent and Trademark Office. The USPTO has given the CANNABASE trademark a serial number of 87323768. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 14, 2020. This trademark is owned by Transderma Pharmaceuticals Inc.. The CANNABASE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical cream base for use in compounding as a transdermal delivery system of medicinal and active pharmaceutical ingredients, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
cannabase

General Information

Serial Number87323768
Word MarkCANNABASE
Filing DateFriday, February 3, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, January 14, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 14, 2017

Trademark Statements

Goods and ServicesPharmaceutical cream base for use in compounding as a transdermal delivery system of medicinal and active pharmaceutical ingredients, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 8, 2017
Primary Code005
First Use Anywhere DateFriday, July 13, 2018
First Use In Commerce DateTuesday, February 26, 2019

Trademark Owner History

Party NameTransderma Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCoquitlam, BC V3K6C2
CA
Party NameTransderma Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCoquitlam, BC V3K6C2
CA

Trademark Events

Event DateEvent Description
Tuesday, January 14, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, January 14, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, August 1, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 1, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 3, 2019NON-FINAL ACTION E-MAILED
Wednesday, July 3, 2019SU - NON-FINAL ACTION - WRITTEN
Saturday, April 20, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, April 8, 2019USE AMENDMENT FILED
Saturday, April 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 8, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, January 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 7, 2019EXTENSION 2 GRANTED
Monday, January 7, 2019EXTENSION 2 FILED
Monday, January 7, 2019TEAS EXTENSION RECEIVED
Thursday, June 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 12, 2018EXTENSION 1 GRANTED
Tuesday, June 12, 2018EXTENSION 1 FILED
Tuesday, June 12, 2018TEAS EXTENSION RECEIVED
Tuesday, January 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 25, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 9, 2017ASSIGNED TO LIE
Wednesday, September 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 6, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 22, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 22, 2017NON-FINAL ACTION E-MAILED
Tuesday, August 22, 2017NON-FINAL ACTION WRITTEN
Monday, August 14, 2017ASSIGNED TO EXAMINER
Wednesday, April 12, 2017ASSIGNED TO EXAMINER
Tuesday, February 21, 2017ASSIGNED TO EXAMINER
Tuesday, February 21, 2017ASSIGNED TO EXAMINER
Wednesday, February 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 7, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

cannabase delivery pharmaceutical compounds agents consisting facilitate pharmaceuticals range wide drug